amortization) were Thai Baht 195.04 million in 2019 or 51.88% more than Thai Baht 128.42 million in 2018. The variance was mostly due to an increase in employee expenses and sales promotion expenses. EBITDA
-year from Baht 27.64 million in 1Q18. The variance was mostly due to an increase in number of patients, depreciation and employee management expenses. EBITDA increased by 112.55% year- over-year to Baht
variance was mostly due to an increase in employee expenses. Profit to equity holders of the company in 1Q20 decreased by 74.83% year‐over‐year to THB 11.25 million from THB 44.70 million in
: million baht April-June January-June 2019 2018 Variance 2019 2018 Variance MB % MB % Net profit (loss) for the period (698.1) (82.0) (616.1) (751.3) (187.2) 637.3 (824.5) (129.4) Plus: Finance Cost 429.6
baht July-September January-September 2018 2017 Variance 2018 2017 Variance Amount % Amount % Net profit (loss) for the period 39.6 (142.2) 181.8 127.9 676.9 (97.8) 774.7 792.2 Plus: Finance Cost 475.5
results for the 2nd quarter of 2019 which has variance of over 20 percent comparing to the same period of the previous year. The relevant details are as follows:- “Net earned premium” and “Commission and
amortization) were Baht 47.33 million or 70.39% increase year-over-year from Baht 27.78 million in 2Q18. The variance was mostly due to an increase in revenues, depreciation and employee management expenses
and amortization) were Baht 33.12 million for 3Q18, or 33.23% increase year-over-year from Baht 24.86 million in 3Q17. The variance was mostly due to an increase in revenues, depreciation and employee
. The variance was mostly due to an increase in selling expenses resulted from an increase in number of patients and an increase in employee management expenses. Profit to equity holders of the company
Baht 53.37 million. When compared to the administrative expense in 2016, the total difference declines in the amount of Baht 18.17 million or 25.39%. This is because there is no an allowance for doubtful